search
Back to results

Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions (CSI-Ulm-CTO)

Primary Purpose

Coronary Artery Disease, Ischemic Heart Disease, Stable Angina

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
stent or scaffold
Sponsored by
University of Ulm
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Coronary Artery Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • coronary artery disease
  • chronic total occlusion

Exclusion Criteria:

  • no written informed consent

Sites / Locations

  • University of Ulm

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

stent or scaffold

Arm Description

implantation of stents or scaffolds after recanalization of coronary chronic total occlusions

Outcomes

Primary Outcome Measures

Major adverse cardiac events

Secondary Outcome Measures

Full Information

First Posted
June 7, 2014
Last Updated
April 25, 2020
Sponsor
University of Ulm
search

1. Study Identification

Unique Protocol Identification Number
NCT02162082
Brief Title
Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions
Acronym
CSI-Ulm-CTO
Official Title
Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
June 2014 (undefined)
Primary Completion Date
December 31, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Ulm

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To evaluate the long-term results after recanalization of coronary chronic total occlusions.
Detailed Description
Patients with successful recanalization of coronary chronic total occlusions are followed during a period of 5 years to demonstrate safety and efficacy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Ischemic Heart Disease, Stable Angina

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
198 (Actual)

8. Arms, Groups, and Interventions

Arm Title
stent or scaffold
Arm Type
Experimental
Arm Description
implantation of stents or scaffolds after recanalization of coronary chronic total occlusions
Intervention Type
Device
Intervention Name(s)
stent or scaffold
Intervention Description
implantation of a CE certified drug-eluting stent, bare-metal stent or scaffold
Primary Outcome Measure Information:
Title
Major adverse cardiac events
Time Frame
1-5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: coronary artery disease chronic total occlusion Exclusion Criteria: no written informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jochen Wöhrle, MD
Organizational Affiliation
University of Ulm, Ulm, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Ulm
City
Ulm
ZIP/Postal Code
89081
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
27845998
Citation
Kugler C, Markovic S, Rottbauer W, Wohrle J. Bioresorbable scaffolds compared with everolimus-eluting stents for the treatment of chronic coronary total occlusion: clinical and angiographic results of a matched paired comparison. Coron Artery Dis. 2017 Mar;28(2):120-125. doi: 10.1097/MCA.0000000000000449.
Results Reference
derived

Learn more about this trial

Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions

We'll reach out to this number within 24 hrs